Chemoinformaics analysis of 9-Octadecenoic acid (z)-
| Molecular Weight | 282.468 | nRot | 15 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 2 |
| Exact Molecular Weight | 282.256 | nRing | 0 |
| Solubility: LogS | -3.308 | nHRing | 0 |
| Solubility: LogP | 6.169 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.335 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.291 |
| Synth | 2.033 |
| Natural Product Likeliness | 0.869 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.035 |
| CACO-2 | -5.043 |
| MDCK | 0.0000357 |
| BBB | 0.021 |
| PPB | 0.990832 |
| VDSS | 0.718 |
| FU | 0.00563956 |
| CYP1A2-inh | 0.269 |
| CYP1A2-sub | 0.206 |
| CYP2c19-inh | 0.204 |
| CYP2c19-sub | 0.096 |
| CYP2c9-inh | 0.202 |
| CYP2c9-sub | 0.991 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.022 |
| CL | 2.63 |
| T12 | 0.811 |
| hERG | 0.06 |
| Ames | 0.015 |
| ROA | 0.037 |
| SkinSen | 0.939 |
| Carcinogencity | 0.095 |
| EI | 0.967 |
| Respiratory | 0.849 |
| NR-Aromatase | 0.072 |
| Antiviral | Yes |
| Prediction | 0.576912 |